Guo S - Search Results

1

Individualized management of hepatic diseases in hereditary hemorrhagic telangiectasia.

Song X, Chen HQ, Chen YX, Cheng Y, Qu CQ, Liu EY, Guo S, Xu KS, Niu J, Shou NH. Song X, et al. Among authors: guo s. Am Surg. 2011 Mar;77(3):281-5. Am Surg. 2011. PMID: 21375837

2

Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6.

Zhao R, Liu XQ, Wu XP, Liu YF, Zhang ZY, Yang GY, Guo S, Niu J, Wang JY, Xu KS. Zhao R, et al. Among authors: guo s. Cancer Lett. 2010 Jan 28;287(2):150-6. doi: 10.1016/j.canlet.2009.06.006. Epub 2009 Jul 5. Cancer Lett. 2010. PMID: 19581046

3

Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.

Liu YF, Zhao R, Guo S, Wang XQ, Lian PL, Chen YG, Xu KS. Liu YF, et al. Among authors: guo s. Ann Surg Oncol. 2011 Mar;18(3):872-9. doi: 10.1245/s10434-010-1303-x. Epub 2010 Sep 17. Ann Surg Oncol. 2011. PMID: 20848225

4

Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer.

Liu YF, Guo S, Zhao R, Chen YG, Wang XQ, Xu KS. Liu YF, et al. Among authors: guo s. World J Surg. 2012 Jan;36(1):109-17. doi: 10.1007/s00268-011-1192-6. World J Surg. 2012. PMID: 21773953

5

TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.

Ning S, Guo S, Xie J, Xu Y, Lu X, Chen Y. Ning S, et al. Among authors: guo s. J Gastrointest Surg. 2013 Feb;17(2):360-8. doi: 10.1007/s11605-012-2105-1. Epub 2012 Dec 1. J Gastrointest Surg. 2013. PMID: 23207686

6

Validation of the laparoscopically stapled approach as a standard technique for left lateral segment liver resection.

Wang X, Li J, Wang H, Luo Y, Ji W, Duan W, Zhang X, Guo S, Xu K, Dong J, Zheng S. Wang X, et al. Among authors: guo s. World J Surg. 2013 Apr;37(4):806-11. doi: 10.1007/s00268-013-1912-1. World J Surg. 2013. PMID: 23329421

7

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, Ning SL, Yang H, Suo N, Chen YX. Xu YF, et al. Among authors: guo s. Biochem Biophys Res Commun. 2014 Mar 28;446(1):54-60. doi: 10.1016/j.bbrc.2014.02.050. Epub 2014 Feb 22. Biochem Biophys Res Commun. 2014. PMID: 24565842

8

Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.

Yang XQ, Xu YF, Guo S, Liu Y, Ning SL, Lu XF, Yang H, Chen YX. Yang XQ, et al. Among authors: guo s. World J Gastroenterol. 2014 Apr 14;20(14):4076-84. doi: 10.3748/wjg.v20.i14.4076. World J Gastroenterol. 2014. PMID: 24744599 Free PMC article.

9

Clinical significance of integrin β6 as a tumor recurrence factor in follicular thyroid carcinoma.

Zhuang ZN, Xu ZJ, Zhou Q, Xu XZ, Tian J, Liu YF, Guo S, Wang JY, Xu KS. Zhuang ZN, et al. Among authors: guo s. Head Neck. 2015 Oct;37(10):1439-47. doi: 10.1002/hed.23780. Epub 2014 Jul 21. Head Neck. 2015. PMID: 24844802

10

Application of air insufflation to prevent clinical pancreatic fistula after pancreaticoduodenectomy.

Yang H, Lu XF, Xu YF, Liu HD, Guo S, Liu Y, Chen YX. Yang H, et al. Among authors: guo s. World J Gastroenterol. 2015 Feb 14;21(6):1872-9. doi: 10.3748/wjg.v21.i6.1872. World J Gastroenterol. 2015. PMID: 25684954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,000 results

Search Page

Filters